天新药业(603235.SH)：前三季度净利润4.6亿元，同比下降6.91%

Core Viewpoint - Tianxin Pharmaceutical (603235.SH) reported a slight increase in total operating revenue for the first three quarters of 2025, but a decline in net profit attributable to shareholders [1] Financial Performance - Total operating revenue reached 1.631 billion yuan, reflecting a year-on-year growth of 1.08% [1] - Net profit attributable to shareholders was 460 million yuan, showing a year-on-year decrease of 6.91% [1] - Basic earnings per share stood at 1.06 yuan [1]